SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Speaker
James Wymer, MD, PHD, CPI, FAAN
University of Florida
Professor of Neurology, Director of Neuromuscular Division
Professor of Neurology
Gainesville, FL


Moderator
Gregg Sherman, MD
Family Practice
Plantation, FL

Title
: Recognizing and Appropriately Managing Pseudobulbar Affect in the Nursing Home Setting
Activity/Course #:
: NCME375
Cost:
: Free
Release/Start Date:
: Jun 17 2019
Expiration Date:
: Jun 17 2020
Topics:
: Psychiatry
Target Audience:
: Physicians, Nurse Practitioners and Physician Assistants that care for patients in nursing homes and long-term care settings
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.50 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary
PBA may occur in association with a variety of neurological diseases, with prevalence rates ranging from 5% to over 50%, depending on diagnostic criteria, methodologies, and patient populations studied. Among nursing home residents, a recent survey found that PBA symptoms were present in 17.5% of residents with neurological conditions, and 9.0% of residents overall. A systematic review and meta-analysis of published literature documented PBA in approximately 1 in 5 stroke survivors at the acute and post-acute phases, and 1 in 8 survivors beyond 6 months post-stroke.

This activity will examine the strategies for diagnosis of PBA, review the therapeutic options, and special considerations for management of PBA in the nursing home setting.

Learning Objectives
After completing this program participants should be able to:
  1. Describe the prevalence and impact of pseudobulbar affect (PBA) among nursing home residents
  2. Outline strategies for the identification of PBA in the nursing home
  3. Review therapeutic options for PBA
  4. Describe special considerations for the management of PBA among nursing home residents
How to obtain the CME Certificate
  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 contact hour of continuing education which includes 0.50 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosures are provided below.

Speaker
James Wymer, MD, PHD, CPI, FAAN, has no relationships to disclose.

Contributing Faculty
Dr. Gustavo Alva, MD, DFAPA has served as a consultant for Acadia, Allergan, Avanir, ITI, Neurocrine, Takeda, Teva, Lundbeck Otsuka, Sunovion, Janssen, and Merk. He is also a member of the Speakers' Bureau for Acadia, Allergan, Avanir, Neurocrine, Takeda, Teva, Lundbeck, Otsuka, Sunovion, and Janssen. He has also received research support from Novartis, Genentech, Tau Rx, Lundbeck, Eisai, PrecisionMed, Allergan, Acadia, Axsome, ITI, Suven, Astrostem, and Janssen.

Dr. Alejandro Alva, MD is a speaker for Sunovion Pharmaceuticals and Takeda Pharmaceuticals.

Activity Planning Committe
Gregg Sherman, MD, Course Director, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Daniela Hiedra, BA, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.

Alan Goodstat, LCSW, Activity Planning Committee, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Avanir Pharmaceuticals.